FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma

BWG (Bas) van Rhijn; Theodorus Kwast; AN (André) Vis; WJ (Wim) Kirkels; Egbert Boeve; Q (Quirijn) Jobsis; Ellen Zwarthoff

doi:10.1158/0008-5472.CAN-03-2421

FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma

BWG (Bas) van Rhijn, Theodorus Kwast, AN (André) Vis, WJ (Wim) Kirkels, Egbert Boeve, Q (Quirijn) Jobsis, Ellen Zwarthoff

Research output: Contribution to journal › Article › Academic › peer-review

195 Citations (Scopus)

26 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	1911-1914
Number of pages	4
Journal	Cancer Research
Volume	64
DOIs	https://doi.org/10.1158/0008-5472.CAN-03-2421
Publication status	Published - 2004

Research programs

EMC MM-03-24-02
EMC MM-03-49-01

Access to Document

10.1158/0008-5472.CAN-03-2421

15026322.pdfFinal published version, 104 KB

http://hdl.handle.net/1765/10322

Cite this

@article{8e016aa08f35490ea0d232febb0fd7d5,

title = "FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma",

author = "{van Rhijn}, {BWG (Bas)} and Theodorus Kwast and Vis, {AN (Andr{\'e})} and Kirkels, {WJ (Wim)} and Egbert Boeve and Jobsis, {Q (Quirijn)} and Ellen Zwarthoff",

year = "2004",

doi = "10.1158/0008-5472.CAN-03-2421",

language = "Undefined/Unknown",

volume = "64",

pages = "1911--1914",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

}

TY - JOUR

T1 - FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma

AU - van Rhijn, BWG (Bas)

AU - Kwast, Theodorus

AU - Vis, AN (André)

AU - Kirkels, WJ (Wim)

AU - Boeve, Egbert

AU - Jobsis, Q (Quirijn)

AU - Zwarthoff, Ellen

PY - 2004

Y1 - 2004

U2 - 10.1158/0008-5472.CAN-03-2421

DO - 10.1158/0008-5472.CAN-03-2421

M3 - Article

SN - 0008-5472

VL - 64

SP - 1911

EP - 1914

JO - Cancer Research

JF - Cancer Research

ER -